These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7774844)

  • 41. Reasons for non-participation in population-based abdominal aortic aneurysm screening.
    Linne A; Leander K; Lindström D; Törnberg S; Hultgren R
    Br J Surg; 2014 Apr; 101(5):481-7. PubMed ID: 24615380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the Costs of Screening for Ovarian Cancer in the United States: An Evolving Analysis.
    Gorski JW; Quattrone M; van Nagell JR; Pavlik EJ
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31991783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Socioeconomic status and cancer screening.
    Segnan N
    IARC Sci Publ; 1997; (138):369-76. PubMed ID: 9353678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Factors affecting national health insurance mass screening participation in the disabled].
    Park JH; Lee JS; Lee JY; Hong JY; Kim SY; Kim SO; Cho BH; Kim YI; Shin Y; Kim Y
    J Prev Med Public Health; 2006 Nov; 39(6):511-9. PubMed ID: 17168205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Women's willingness to pay for cancer screening].
    Kwak MS; Sung NY; Yang JH; Park EC; Choi K
    J Prev Med Public Health; 2006 Jul; 39(4):331-8. PubMed ID: 16910307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Is screening for ovarian cancer beneficial?].
    Andolf E
    Lakartidningen; 1992 Jan; 89(4):187-9. PubMed ID: 1734148
    [No Abstract]   [Full Text] [Related]  

  • 48. Is screening for ovarian cancer worthwhile?
    Philip J
    J Med Screen; 1994 Oct; 1(4):206-7. PubMed ID: 8790519
    [No Abstract]   [Full Text] [Related]  

  • 49. [UL-scanning for ovarian cancer].
    Tabor A; Hornnes PJ; Ottesen BS
    Ugeskr Laeger; 1997 Mar; 159(10):1461-3. PubMed ID: 9082636
    [No Abstract]   [Full Text] [Related]  

  • 50. Ovarian cancer screening.
    Gosink BB
    Am J Obstet Gynecol; 1992 May; 166(5):1591-3. PubMed ID: 1595819
    [No Abstract]   [Full Text] [Related]  

  • 51. Ovarian cancer screening in the general population.
    Menon U; Jacobs I
    Ultrasound Obstet Gynecol; 2000 May; 15(5):350-3. PubMed ID: 10976473
    [No Abstract]   [Full Text] [Related]  

  • 52. When and whom to screen.
    Lindow TE
    Ann Intern Med; 1993 Dec; 119(11):1151-2. PubMed ID: 8239244
    [No Abstract]   [Full Text] [Related]  

  • 53. Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.
    Zhou HJ; Li SC; Naidoo N; Zhu F; Yeoh KG
    BMC Health Serv Res; 2013 Apr; 13():139. PubMed ID: 23587354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with return for routine annual screening in an ovarian cancer screening program.
    Andrykowski MA; Zhang M; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2007 Mar; 104(3):695-701. PubMed ID: 17145075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Making decisions about screening for ovarian cancer. Who chooses when an operation is worth having?
    Barratt A
    BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10742017
    [No Abstract]   [Full Text] [Related]  

  • 56. Participation in transvaginal ovarian cancer screening: compliance, correlation factors, and costs.
    Pavlik EJ; van Nagell JR; DePriest PD; Wheeler L; Tatman JM; Boone M; Sollars S; Rayens MK; Kryscio RK
    Gynecol Oncol; 1995 Jun; 57(3):395-400. PubMed ID: 7774844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuing participation supports ultrasound screening for ovarian cancer.
    Pavlik EJ; Johnson TL; Depriest PD; Andrykowski MA; Kryscio RJ; Van Nagell JR
    Ultrasound Obstet Gynecol; 2000 May; 15(5):354-64. PubMed ID: 10976474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
    Lykins EL; Pavlik EL; Andrykowski MA
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Is ultrasound screening for ovarian cancer possible in 1998?].
    Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.